Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions-Reference-Cited by-同舟云学术

Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions

Published:2017-03 Issue:6 Volume:10 Page:560-568
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Geraci Salvatore,Kawamoto Hiroyoshi,Caramanno Giuseppe,Ruparelia Neil,Capodanno Davide,Brugaletta Salvatore,Gori Tommaso,Nef Holger,Sabate Manel,Mehilli Julinda,Lesiak Maciej,Naber Christoph,Di Mario Carlo,Capranzano Piera,Wiebe Jens,Araszkiewicz Aleksander,Pyxaras Stelios,Mattesini Alessio,Münzel Thomas,Tamburino Corrado,Colombo Antonio,Latib Azeem

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial;Boden;Am J Cardiol,2007

2. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions;Kim;Catheter Cardiovasc Interv,2006

3. Long-term outcomes after coronary bare-metal-stent and drug-eluting-stent implantations: a ‘real-world’ comparison among patients with diabetes with diffuse small vessel coronary artery disease;Koh;Coron Artery Dis,2011

4. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents;Iakovou;JAMA,2005

5. Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition;Foin;Circ Cardiovasc Interv,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy;Journal of the Society for Cardiovascular Angiography & Interventions;2022-01

2. Bioresorbable Vascular Scaffolds—Dead End or Still a Rough Diamond?;Journal of Clinical Medicine;2019-12-07

3. Two-year clinical outcomes of the “Italian diffuse/multivessel disease absorb prospective registry” (IT-DISAPPEARS);International Journal of Cardiology;2019-09

4. Percutaneous coronary interventions with the Absorb Bioresorbable vascular scaffold in real life: 1-year results from the FRANCE ABSORB registry;Archives of Cardiovascular Diseases;2019-02

5. Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique;BMC Cardiovascular Disorders;2019-01-18